Next Article in Journal
Viral Interactions with PDZ Domain-Containing Proteins—An Oncogenic Trait?
Next Article in Special Issue
Application and Optimization of relE as a Negative Selection Marker for Making Definitive Genetic Constructs in Uropathogenic Escherichia coli
Previous Article in Journal
How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions
Previous Article in Special Issue
Pathogens, Commensals, and Immunity: From the Perspective of the Urinary Bladder
Conference Report

Measuring Escherichia coli Gene Expression during Human Urinary Tract Infections

Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
Academic Editor: Catharina Svanborg
Pathogens 2016, 5(1), 7; https://doi.org/10.3390/pathogens5010007
Received: 11 September 2015 / Revised: 13 January 2016 / Accepted: 13 January 2016 / Published: 15 January 2016
(This article belongs to the Special Issue Molecular Aspects of Urinary Tract Infection)
Extraintestinal Escherichia coli (E. coli) evolved by acquisition of pathogenicity islands, phage, plasmids, and DNA segments by horizontal gene transfer. Strains are heterogeneous but virulent uropathogenic isolates more often have specific fimbriae, toxins, and iron receptors than commensal strains. One may ask whether it is the virulence factors alone that are required to establish infection. While these virulence factors clearly contribute strongly to pathogenesis, bacteria must survive by metabolizing nutrients available to them. By constructing mutants in all major metabolic pathways and co-challenging mice transurethrally with each mutant and the wild type strain, we identified which major metabolic pathways are required to infect the urinary tract. We must also ask what else is E. coli doing in vivo? To answer this question, we examined the transcriptome of E. coli CFT073 in the murine model of urinary tract infection (UTI) as well as for E. coli strains collected and analyzed directly from the urine of patients attending either a urology clinic or a university health clinic for symptoms of UTI. Using microarrays and RNA-seq, we measured in vivo gene expression for these uropathogenic E. coli strains, identifying genes upregulated during murine and human UTI. Our findings allow us to propose a new definition of bacterial virulence. View Full-Text
Keywords: E. coli; urinary tract infection; in vivo gene expression; RNA-seq E. coli; urinary tract infection; in vivo gene expression; RNA-seq
Show Figures

Figure 1

MDPI and ACS Style

Mobley, H.L.T. Measuring Escherichia coli Gene Expression during Human Urinary Tract Infections. Pathogens 2016, 5, 7. https://doi.org/10.3390/pathogens5010007

AMA Style

Mobley HLT. Measuring Escherichia coli Gene Expression during Human Urinary Tract Infections. Pathogens. 2016; 5(1):7. https://doi.org/10.3390/pathogens5010007

Chicago/Turabian Style

Mobley, Harry L.T. 2016. "Measuring Escherichia coli Gene Expression during Human Urinary Tract Infections" Pathogens 5, no. 1: 7. https://doi.org/10.3390/pathogens5010007

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop